The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index; 3 of the 123 sources its claims cite were checked for support.
The common biology of cancer and ageing
Abstract
At first glance, cancer and ageing would seem to be unlikely bedfellows. Yet the origins for this improbable union can actually be traced back to a sequence of tragic--and some say unethical--events that unfolded more than half a century ago. Here we review the series of key observations that has led to a complex but growing convergence between our understanding of the biology of ageing and the mechanisms that underlie cancer.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review traces historical and molecular convergence between cancer and ageing, focusing on cellular senescence, genomic instability, telomeres, autophagy, and metabolism. It argues that cancer and ageing are often—but not always—woven by similar molecular threads, with some protective mechanisms acting antagonistically and others sharing common aetiologies.
Key findings
- Cellular senescence: Hayflick and Moorhead found normal diploid fibroblasts could not be subcultivated more than about 50 times; p16INK4a increases with ageing and is described as an impressively good biomarker of ageing, while also limiting stem cell renewal and tissue regeneration.
- Genomic instability: severe DNA damage-sensing/repair defects can accelerate ageing, whereas milder mutations in the same pathways predispose to cancer; “superactive” p53 mice are cancer-resistant but age prematurely, while normally regulated p53 overexpression does not change lifespan.
- Telomeres and telomerase: telomere shortening predicts replicative capacity and age-associated pathologies; more than 95% of human tumours aberrantly activate telomerase, and Terc-deficient mice show decreased median and maximum lifespan with disease anticipation.
- Autophagy and metabolism: Becn1 haploinsufficient mice develop tumours; Atg5-null mice die within the first 24 h of life; brain-specific Atg5/Atg7 knockouts show shortened lifespan and age-related neurodegeneration; TOR inhibition and caloric restriction extend lifespan in model organisms.
Methods
- Narrative review, not primary research; synthesizes historical observations and recent experimental highlights across five areas: cellular senescence and tumour formation, genomic instability, telomere biology, autophagy, and mitochondrial metabolism/energy-dependent signal transduction.
- Data/sample: published literature and referenced studies, including human inherited syndromes, mouse models, yeast, C. elegans, Drosophila, and cell culture; no new experiments or systematic search strategy are described.
- Main analysis: conceptual synthesis and model-building, with figures proposing interplay between stem cells, stress, ageing, cancer, telomeres, autophagy, and energy signal transduction.
Limitations
- Stated in the paper: many fundamental questions remain unanswered; the exact mechanistic link between cancer and autophagy remains obscure; the hierarchy and crosstalk between CDKN2a induction and DNA damage response activation in vivo are not well understood; extension of accelerated ageing models to normal ageing must be done with care; and autophagy’s role in postmitotic C. elegans may be more important than in renewable mammalian systems.
- Evident from the text: as a narrative review, it lacks a systematic literature search or quantitative synthesis, and its proposed models are speculative rather than validated by primary data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
84 Not checked yet · 34 Own interpretation · 15 No basis given · 1 Supported · 1 Supported so far · 1 Own result
Every source the paper cites for this claim was checked and supports it.
In the paper
“One caveat to such an approach is the observation that increased telomerase activity in two independent Tert transgenic mouse models seemed to increase the susceptibility for tumour formation 66, 67 .”
What the sources say
- Supportedcites [66] Gonzalez-Suarez, E. et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 20, 2619–2630 (2001) source
The Conclusions report that K5-mTERT mice were significantly more susceptible to neoplasias than wild-type littermates after DMBA and TPA skin treatment. This paper supplies one of the transgenic mouse models invoked by the citing sentence; it does not need to establish the second model cited there. (LLM, conf=0.90)
- Supportedcites [67] Artandi, S. E. et al. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl Acad. Sci. USA 99, 8191–8196 (2002) source
The Discussion reports increased mammary neoplasia and invasive breast cancer in this paper’s aging mTERT transgenic mice. It also describes a separate keratin-5–mTERT transgenic model with increased susceptibility to papillomas after chemical carcinogen treatment. The tumour types and conditions differed between the two models. (LLM, conf=0.91)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“the critical executioners of senescence in response to the above factors seem to include the well known tumour suppressor pathways that are controlled by retinoblastoma 1 (RB1) and P53”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“strategies such as caloric restriction, which extend lifespan, also seem to reverse the age-dependent increase in p16INK4a transcription 16, 18”
What the sources say
- Not checked yetcites [16] Krishnamurthy, J. et al. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114, 1299–1307 (2004) source
- Not checked yetcites [18] Edwards, M. G. et al. Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program. BMC Genomics 8, 80 (2007) source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tumour progression to full malignancy is favoured when tumour cells acquire mutations that impair the senescence program (for example, mutations in Trp53 or CDKN2a ).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“recent data have shown that there are abundant senescent cells within tumours”
What the sources say
- Not checked yetcites [5] Mooi, W. J. & Peeper, D. S. Oncogene-induced cell senescence—halting on the road to cancer. N. Engl. J. Med. 355, 1037–1046 (2006) source
- Not checked yetcites [6] Collado, M. & Serrano, M. The power and the promise of oncogene-induced senescence markers. Nature Rev. Cancer 6, 472–476 (2006) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During normal ageing, stem cells accumulate damage and subsequent stress-dependent changes (for example, de-repression of the CDKN2a ( INK4a / ARF ) locus or telomere shortening). This leads to the increasing abundance of senescent cells (large blue cells) within differentiated tissues.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“This intra-tumoral senescence is thought to be triggered mainly by oncogenic signals that can function in part by de-repressing the CDKN2a locus.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The CDKN2a locus is normally expressed at very low levels in most tissues of young organisms 16”
What the sources say
- Not checked yetcites [16] Krishnamurthy, J. et al. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114, 1299–1307 (2004) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Another crucial mediator of oncogene-induced senescence seems to be the activation of the DNA damage response (DDR) pathway, presumably by the hyper-replication that is characteristic of cancer cells 8, 9”
What the sources say
- Not checked yetcites [8] Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633–637 (2006) source
- Not checked yetcites [9] Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638–642 (2006) source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“it was observed that the levels of p16INK4a increased progressively with the proliferative history of cells in culture 3, 4”
What the sources say
- Not checked yetcites [3] Alcorta, D. A. et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl Acad. Sci. USA 93, 13742–13747 (1996) source
- Not checked yetcites [4] Hara, E. et al. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16, 859–867 (1996) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 41
- Probably not a substantial claim. 17
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“For our purpose, suffice it to say that TOR is activated in the presence of abundant nutrients, and inactivated under starvation.”
What the sources say
- Not checked yetcites [85] Sabatini, D. M. mTOR and cancer: insights into a complex relationship. Nature Rev. Cancer 6, 729–734 (2006) source
- Supportedcites [86] Wullschleger, S., Loewith, R. & Hall, M. N. TOR signaling in growth and metabolism. Cell 124, 471–484 (2006) source
The Nutrients section (p. 6) reports that amino acid starvation rapidly reduces phosphorylation of mTORC1 effectors, while reintroducing amino acids restores it. The Physiological Roles section (p. 3) likewise says TOR is active when growth conditions are favorable and describes reduced growth-related activity during nitrogen starvation. Together, these support the sentence’s broad summary of nutrient-dependent TOR signaling. (LLM, conf=0.91)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“they concluded that some intrinsic factor/s (later termed 'Hayflick factors') accumulated in these cells until they 'senesced' 1”
What the sources say
- Not checked yetcites [1] Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585–621 (1961) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Incipient tumours, arising directly from stem cells or from more committed cells, undergo rapid proliferation (small red cells). These pre-malignant tumour cells rapidly accumulate damage, in part owing to the presence of oncogenes, leading to a higher proportion of tumour cells becoming senescent (small blue cells).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“It is well established that the CDKN2a locus is activated during organismal ageing in both rodents and humans, and the levels of p16INK4a constitute an impressively good overall biomarker of ageing 16, 17”
What the sources say
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The CDKN2a locus encodes two separate proteins including p16INK4a, which regulates RB1 activity by directly inhibiting the cyclin-dependent kinases, and p19ARF, which regulates the function of P53.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“reducing the level of various mitotic checkpoint genes leads to chromosomal instability, augmented aneuploidy and the phenotypic appearance of progeroid mice 36, 37”
What the sources say
- Not checked yetcites [36] Baker, D. J. et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature Genet. 36, 744–749 (2004) source
- Not checked yetcites [37] Baker, D. J. et al. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J. Cell Biol. 172, 529–540 (2006) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“evidence from cell culture models indicates that Sirt1 is involved in heterochromatin formation and might be particularly important in the silencing of certain tumour suppressors 45, 46”
What the sources say
- Not checked yetcites [45] Vaquero, A. et al. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol. Cell 16, 93–105 (2004) source
- Not checked yetcites [46] Pruitt, K. et al. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet. 2, e40 (2006) source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“mice with a targeted deletion in Sirt6 manifest an accelerated ageing phenotype that on a cellular level is accompanied by genomic instability and defects in DNA repair 47”
What the sources say
- Not checked yetcites [47] Mostoslavsky, R. et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315–329 (2006) source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cloning of additional telomeres revealed that they are highly conserved in most eukaryotic organisms, with the exception of some flies.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The Sirt6 -deficient mice therefore add to a growing but poorly understood connection between genomic instability and altered IGF-1 signalling, as insulin-IGF signalling is also perturbed in other mouse models of accelerated ageing, including animals with increased p53 activity 30 and mice lacking the NER enzyme ERCC4 39”
What the sources say
- Not checked yetcites [30] Maier, B. et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 18, 306–319 (2004) source
- Not checked yetcites [39] Niedernhofer, L. J. et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444, 1038–1043 (2006) source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“One attractive explanation is that WRN is essential for proper telomere maintenance through its interaction with the telomeric binding proteins TERF1 and TERF2 41”
What the sources say
- Not checked yetcites [41] Opresko, P. L. et al. The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol. Cell 14, 763–774 (2004) source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“not every strategy that could protect us from cancer comes at the expense of accelerating ageing.”
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“this accelerated ageing phenotype might be unique to expression of these altered forms of 'superactive' p53, as simple transgenic overexpression of full-length p53 using its endogenous promoter to regulate expression does not result in a change in lifespan 31”
What the sources say
- Not checked yetcites [31] Garcia-Cao, I. et al. “Super p53” mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21, 6225–6235 (2002) source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“This telomere elongation was proposed to rely either on recombination events between telomeres or on the existence of a novel enzymatic activity that could synthesize telomere repeats de novo .”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Telomeres were found to consist of tandem G-rich repeats that expanded until the chromosome end.”
What the sources say
- Not checked yetcites [48] Blackburn, E. H. & Gall, J. G. A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J. Mol. Biol. 120, 33–53 (1978) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“insulin-IGF signalling is known to regulate lifespan in lower organisms.”
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In yeast, Sir2 has been implicated in the increase in lifespan that is seen after caloric restriction and in both yeast and worms, overexpression of Sir2 is sufficient to extend lifespan.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In each of these cases, ageing is the apparent result of either a chronic increase in the level of DNA damage (ATM and BRCA1 deficiency) or the presumed chronic engagement of DNA damage signalling ('superactive' p53).”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“This family of enzymes is conserved from Eschericia coli to man, and humans have five RecQ homologues that have important roles in recombination, the replication stress response and maintaining genomic stability.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“The identification of telomeres rapidly led to the realization that some cells could elongate preexisting telomeres, implying the existence of telomere elongation mechanisms 49”
What the sources say
- Not checked yetcites [49] Shampay, J., Szostak, J. W. & Blackburn, E. H. DNA sequences of telomeres maintained in yeast. Nature 310, 154–157 (1984) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“mice lacking Atm show rapid ageing and depletion of their haematopoietic stem cell compartment 34”
What the sources say
- Not checked yetcites [34] Ito, K. et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431, 997–1002 (2004) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These conditions can be caused by germline mutations in the genes for P53, the ataxia-telangiectasia mutated (ATM) kinase and breast cancer 1 (BRCA1), respectively-three proteins that are essential in the surveillance of DNA damage.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Such an enzymatic activity was soon discovered by Carol Greider and Elizabeth Blackburn and was named telomerase 50”
What the sources say
- Not checked yetcites [50] Greider, C. W. & Blackburn, E. H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405–413 (1985) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“the gene responsible for the progeroid Hutchinson-Gilford syndrome has also been identified, and there is evidence that its product helps to maintain nuclear architecture and to regulate genomic stability 43”
What the sources say
- Not checked yetcites [43] Liu, B. et al. Genomic instability in laminopathy-based premature aging. Nature Med. 11, 780–785 (2005) source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together these observations indicate that severe deficiencies in proteins that are involved in DNA damage sensing and DNA repair might accelerate ageing, while milder mutations in these same pathways might predispose individuals to cancer.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Alternatively, the absence of DNA repair might cause enough direct damage to fully differentiated cells to impair overall homeostasis.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“mice that are genetically engineered to express altered isoforms of p53 with increased activity seem to be resistant to cancer but age prematurely 29, 30”
What the sources say
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“One common feature of the sirtuins is their enzymatic function as NAD-dependent deacetylases and for yeast Sir2, this biochemical activity is required for the proteins' ability to regulate silencing, recombination and genomic stability 44”
What the sources say
- Not checked yetcites [44] Haigis, M. C. & Guarente, L. P. Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20, 2913–2921 (2006) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Seven mammalian sirtuins have been identified, with the closest mammalian homologue to yeast Sir2 being Sirt1.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These observations point to p16INK4a both serving as a break for the proliferation of cancer cells, and also limiting the long-term renewal of stem cells.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The removal of damaged cellular components, especially damaged mitochondria, might decrease the level of reactive oxygen species (ROS), which in turn might reduce genomic instability or forestall cellular senescence.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This notion is also supported by observations that in human malignancies the BECN1 locus is commonly deleted and by experimental evidence that several tumour suppressors, including the phosphatase and tensin homologue Pten and p53, stimulate autophagy 78 .”
What the sources say
- Not checked yetcites [78] Kondo, Y. & Kondo, S. Autophagy and cancer therapy. Autophagy 2, 85–90 (2006) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Indeed, although the available evidence indicates that oncogenes can inhibit autophagy and tumour suppressors can stimulate it, the exact mechanistic link between cancer and autophagy remains obscure (Fig. 3).”
What the sources say
- Not checked yetcites [78] Kondo, Y. & Kondo, S. Autophagy and cancer therapy. Autophagy 2, 85–90 (2006) source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Conversely, mice with short telomeres are resistant-with a few exceptions-to tumours 73 , arguing that telomere shortening represents a potent in vivo tumour suppressor mechanism.”
What the sources say
- Not checked yetcites [73] Blanco, R., Muñoz, P., Klatt, P., Flores, J. M. & Blasco, M. A. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. Genes Dev. 21, 206–220 (2007) source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mice lacking autophagy-related gene 5 ( Atg5 ) are born normally but subsequently die within the first 24 h of life 79 . This death is a result of the inability of these mice to activate the macroautophagy program that is required for energy homeostasis immediately after birth.”
What the sources say
- Not checked yetcites [79] Kuma, A. et al. The role of autophagy during the early neonatal starvation period. Nature 432, 1032–1036 (2004) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Such mechanisms might allow moderate increases in autophagy to reduce the incidence of cancer and prolong lifespan.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Conversely, these findings also support the fascinating idea that the manipulation of telomerase activity might increase the life span of mammals.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“Interestingly, both dauer formation and lifespan extension by daf-2 have been shown to require the worm orthologue of beclin 82 .”
What the sources say
- Not checked yetcites [82] Melendez, A. et al. Autophagy genes are essential for dauer development and lifespan extension in C. elegans. Science 301, 1387–1391 (2003) source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“re-introduction of the TERT telomerase gene was sufficient to bypass replicative senescence and to confer immortal growth on a number of human primary cell lines 56”
What the sources say
- Not checked yetcites [56] Bodnar, A. G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349–352 (1998) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In this case, the haploinsufficient mice developed tumours, indicating that autophagy might act as an important in vivo tumour suppressor 76, 77 .”
What the sources say
- Not checked yetcites [76] Yue, Z., Jin, S., Yang, C., Levine, A. J. & Heintz, N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl Acad. Sci. USA 100, 15077–15082 (2003) source
- Not checked yetcites [77] Qu, X. et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112, 1809–1820 (2003) source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This phenomenon is also observed in some patients with dyskeratosis congenita, and is likely to be seen in patients with aplastic anaemia or pulmonary fibrosis due to telomerase deficiencies.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“First generation mice lacking the telomerase RNA component Terc show a decrease in both their median and maximum lifespan, and these effects become more pronounced with each subsequent generation 65 .”
What the sources say
- Not checked yetcites [65] García-Cao, I. et al. Increased p53 activity does not accelerate telomere-driven aging. EMBO Rep. 7, 546–552 (2006) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“this progressive telomere loss was proposed to be at the basis of cellular senescence and ageing in the 'telomere hypothesis' 53”
What the sources say
- Not checked yetcites [53] Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458–460 (1990) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Similarly, the use of the TOR inhibitor rapamycin is currently being actively pursued as a treatment for human malignancies 85 .”
What the sources say
- Not checked yetcites [85] Sabatini, D. M. mTOR and cancer: insights into a complex relationship. Nature Rev. Cancer 6, 729–734 (2006) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Over the last decade it has become clear that most human cancers activate telomerase at some point during tumorigenesis, while this activity is largely absent in most normal tissues 70, 71 .”
What the sources say
- Not checked yetcites [70] Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994) source
- Not checked yetcites [71] Counter, C. M., Hirte, H. W., Bacchetti, S. & Harley, C. B. Telomerase activity in human ovarian carcinoma. Proc. Natl Acad. Sci. USA 91, 2900–2904 (1994) source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In spite of their increased mortality due to cancer, these transgenic mice did show evidence of improved tissue regeneration as well as a slight increase in maximum life span 68 .”
What the sources say
- Not checked yetcites [68] Gonzalez-Suarez, E., Geserick, C., Flores, J. M. & Blasco, M. A. Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene 24, 2256–2270 (2005) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“telomere length has been shown to predict the replicative capacity of human cells and the appearance of certain age-associated pathologies in humans 54, 55”
What the sources say
- Not checked yetcites [54] Allsopp, R. C. et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl Acad. Sci. USA 89, 10114–10118 (1992) source
- Not checked yetcites [55] Cawthon, R. M. et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361, 393–395 (2003) source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“One possibility is that interfering with the normal degradation of organelles leads to the retention of older, damaged mitochondria that serve as a source for damaging reactive oxygen species.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Nonetheless, two subsequent studies that used brain-specific conditional knockouts of Atg5 and Atg7 revealed that, in these animals, the absence of autophagy leads to a shortened lifespan and an accelerated form of age-related neuronal degeneration 80, 81 .”
What the sources say
- Not checked yetcites [80] Komatsu, M. et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880–884 (2006) source
- Not checked yetcites [81] Hara, T. et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885–889 (2006) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Such a mechanism would provide a strong connection between common insults that could both contribute to cancer and accelerate ageing.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As more and more stem cells withdraw from the proliferative pool, there is a decrease in the overall number and/or functionality of both stem and progenitor cells. This decrease predisposes the organism to impaired tissue homeostasis and regenerative capacity and could contribute to ageing and age-related pathologies.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Long-lived cells such as stem cells accumulate DNA damage over the lifespan from stresses including intracellular oxidants generated from normal metabolism.
- Rests on an assumption: The default pathway for damaged stem cells is to undergo growth arrest, apoptosis or senescence.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In both of these cases, tumours seem to arise secondary to an increase in metabolic intermediates (succinate and fumarate, respectively).”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“There is also growing evidence that mammalian forkhead family members act as tumour suppressors and regulators of mammalian stem cell lifespan 92, 93, 94 .”
What the sources say
- Not checked yetcites [92] Hu, M. C. et al. IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117, 225–237 (2004) source
- Not checked yetcites [93] Paik, J. H. et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309–323 (2007) source
- Not checked yetcites [94] Tothova, Z. et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128, 325–339 (2007) source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“There is a growing awareness that, as far as the cell is concerned, sensing nutrient availability and energetic status is an integrated and 'system biology' endeavour 101 .”
What the sources say
- Not checked yetcites [101] Levine, A. J., Feng, Z., Mak, T. W., You, H. & Jin, S. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev. 20, 267–275 (2006) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Overall lifespan seems to be influenced by many of these sensors and effectors, indicating that there is an intimate connection between energy sensing and longevity 101 .”
What the sources say
- Not checked yetcites [101] Levine, A. J., Feng, Z., Mak, T. W., You, H. & Jin, S. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev. 20, 267–275 (2006) source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
Most human malignancies develop in the presence of a functional immune system.
“as it is clear that most human malignancies develop in the presence of a functional immune system.”
The paper relies on this without support.
Genomic instability is a hallmark of most cancers.
“Given that genomic instability is a hallmark of most cancers”
The paper relies on this without support.
Telomeres are essential for chromosomal stability.
“Telomeres protect natural chromosome ends from fusion events and are therefore essential for chromosomal stability.”
The paper relies on this without support.
Long-lived cells such as stem cells accumulate DNA damage over the lifespan from stresses including intracellular oxidants generated from normal metabolism.
“Over the lifespan of an organism, longlived cells (such as stem cells) accumulate DNA damage from a number of stresses including intracellular oxidants generated from normal metabolism.”
The paper relies on this without support.
The default pathway for damaged stem cells is to undergo growth arrest, apoptosis or senescence.
“The default pathway for such damaged stem cells is to undergo growth arrest, apoptosis or senescence.”
The authors state this as an assumption.
Some rare cells can escape this normal default pathway by acquiring additional mutations that allow them to continue to proliferate even in the setting of damaged DNA.
“Presumably, some rare cells can escape from this normal default pathway by acquiring additional mutations that allow them to continue to proliferate even in the setting of damaged DNA.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Second, high cellular ROS levels are associated with cancer, diabetes, inflammatory diseases, ischemia-related diseases, and neurodegeneration, and are thus commonly thought to contribute to human pathologies and aging 80–83.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [80]
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Self-citationLoss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Cited by
Sorted by citations
Items 401–500 of 992
Antognazza, M. R., Aziz, I. A., & Lodola, F. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2867516 · Cited by 39
Clear‐Box Machine Learning for Virtual Screening of 2D Nanozymes to Target Tumor Hydrogen Peroxide
Gao, X. J., Yan, J., Zheng, J., Zhong, S., & Gao, X. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202925 · Cited by 39
Singh, A., Yadav, P., Singh, S., Kumar, P., Srikrishna, S., & Singh, V. P. (2023) · Journal of Materials Chemistry C · doi:10.1039/d3tc02554c · Cited by 38
Balakrishnan, M., Chowdhury, S. R., Mukherjee, S., Patra, C. R., & Iyer, P. K. (2015) · RSC Advances · doi:10.1039/c5ra00408j · Cited by 39
Mechanisms Underlying the Anti-Aging and Anti-Tumor Effects of Lithocholic Bile Acid
Arlia‐Ciommo, A., Piano, A., Svistkova, V., Mohtashami, S., & Titorenko, V. I. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150916522 · Cited by 39
Parikh, D., Fouquerel, E., Murphy, C. T., Wang, H., & Opresko, P. L. (2015) · Nature Communications · doi:10.1038/ncomms9214 · Cited by 38
Assessment of the Cytotoxic and Apoptotic Eἀects of Chaetominine in a Human Leukemia Cell Line
Yao, J.-Y., Jiao, R., Liu, C., Zhang, Y., Yu, W., Lu, Y.-H., & Tan, R. X. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.093 · Cited by 38
Ma, Q., Li, X., Zhang, J., Zhu, X., Zhou, L., & Liu, H. (2017) · Analytical Methods · doi:10.1039/c7ay01249g · Cited by 38
Yang, M., Wen, T., Chen, H., Deng, J., Yang, C., & Zhang, Z. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1028-5 · Cited by 38
RetractedHan, H., He, X., Wu, M., Yi, H., Zhao, L., Xu, L., Ma, P., Sun, Y. X., Song, D., & Wang, X. (2020) · Talanta · doi:10.1016/j.talanta.2020.121000 · Cited by 38
Sonawane, P. M., Yudhistira, T., Halle, M. B., Roychaudhury, A., Kim, Y., Surwase, S. S., Bhosale, V. K., Kim, J., Park, H.-S., Kim, Y.-C., et al. (2021) · Dyes and Pigments · doi:10.1016/j.dyepig.2021.109371 · Cited by 38
Two-photon fluorescent probes for quantitative bio-imaging analysis in live tissues
Juvekar, V., Lee, H. W., Lee, D. J., & Kim, H. M. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116787 · Cited by 38
Redox Regulation of Stem and Progenitor Cells
Haneline, L. S. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2141 · Cited by 37
Genetics and Pharmacology of Longevity
Castillo-Quan, J. I., Kinghorn, K. J., & Bjedov, I. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.06.002 · Cited by 37
Li, X. L., Lu, X., Parvathaneni, S., Bilke, S., Zhang, H., Thangavel, S., Vindigni, A., Hara, T., Zhu, Y. J., Meltzer, P. S., et al. (2014) · Cell Cycle · doi:10.4161/cc.29419 · Cited by 37
Hou, T., Zhang, K., Kang, X., Guo, X., Du, L., Chen, X., Yu, L., Yue, J., Ge, H., Liu, Y., et al. (2018) · Talanta · doi:10.1016/j.talanta.2018.12.083 · Cited by 37
Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
Li, J., Li, D., Chen, Y., Chen, W., Xu, J., & Gao, L. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s414714 · Cited by 37
TLC-based detection of methylated cytosine: application to aging epigenetics
Barciszewska, M. Z., Barciszewska, A., & Rattan, S. I. S. (2007) · Biogerontology · doi:10.1007/s10522-007-9109-3 · Cited by 37
Ambient Oxygen Promotes Tumorigenesis
Sung, H. J., Ma, W., Starost, M. F., Lago, C. U., Lim, P. K., Sack, M. N., Kang, J., Wang, P.-Y., & Hwang, P. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019785 · Cited by 39
Huang, X. L., Li, Z., Liu, Z., Zeng, C., & Hu, L. (2019) · Dyes and Pigments · doi:10.1016/j.dyepig.2019.02.042 · Cited by 37
Evolution of Premalignant DiseasePreprint
Curtius, K., Wright, N. A., & Graham, T. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026542 · Cited by 38
Region- and Cell-specific Aneuploidy in Brain Aging and Neurodegeneration
Shepherd, C. E., Yang, Y., & Halliday, G. M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.050 · Cited by 36
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109771 · Cited by 36
Lu, X., Su, H., Zhang, J., Wang, N., Wang, H., Liu, J., & Zhao, W. (2021) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2021.120620 · Cited by 35
Wuethrich, P. Y., Vidal, A. D., & Burkhard, F. C. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.08.011 · Cited by 35
Light-Activated Regulation of Cofilin Dynamics Using a Photocaged Hydrogen Peroxide Generator
Miller, E. W., Taulet, N., Onak, C. S., New, E. J., Lanselle, J. K., Smelick, G. S., & Chang, C. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja107783j · Cited by 36
Age-related vascular gene expression profiling in mice
Rammos, C., Hendgen-Cotta, U. B., Deenen, R., Pohl, J., Stock, P., Hinzmann, C., Kelm, M., & Rassaf, T. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.01.001 · Cited by 35
Reaction-Based Color-Convertible Fluorescent Probe for Ferroptosis Identification
Shi, L., Guan, Q., Gao, X., Jin, X., Xu, L., Shen, J., Wu, C., Zhu, X., & Zhang, C. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01721 · Cited by 36
Zheng, W., Yang, J., Shen, Y., Yao, Y., Lv, G., Hao, S., & Li, C. (2020) · Dyes and Pigments · doi:10.1016/j.dyepig.2020.108404 · Cited by 35
Microgels as Smart Polymer Colloids for Sensing and Environmental Remediation
Kumari, S., Avais, M., & Chattopadhyay, S. (2023) · ACS Applied Polymer Materials · doi:10.1021/acsapm.2c01947 · Cited by 35
Nakade, K., Pan, J., Yamasaki, T., Murata, T., Wasylyk, B., & Yokoyama, K. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808333200 · Cited by 36
Aging: past, present and future
Blagosklonny, M. V., Campisi, J., & Sinclair, D. A. (2009) · Aging · doi:10.18632/aging.100009 · Cited by 35
Guo, H., Deng, Q., Wu, C. H., Hu, L., Wei, S., Xu, P., Kuang, D., Liu, L., Hu, Z., Miao, X., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1409 · Cited by 35
Yao, X., Yao, X., Li, Y., Zhong, K., Tang, L., & Yan, X. (2023) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2023.122882 · Cited by 34
A Powerful Tumor Catalytic Therapy by an Enzyme‐Nanozyme Cascade Catalysis (ENCAT) System
Zhou, M., Feng, J., Mei, Q., Li, T., Zhang, Y., Liu, W., & Wei, H. (2025) · Small · doi:10.1002/smll.202409363 · Cited by 34
Cancer Stem Cells in Colorectal Cancer: Genetic and Epigenetic Changes
Roy, S. (2013) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s7-006 · Cited by 34
Scheers, I., Lombard, C. A., Paganelli, M., Campard, D., Najimi, M., Gala, J., Decottignies, A., & Sokal, E. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071374 · Cited by 34
JQ1, a BET‐bromodomain inhibitor, inhibits human cancer growth and suppresses PD‐L1 expression
Liu, K., Zhou, Z., Gao, H., Yang, F., Qian, Y., Jin, H., Guo, Y., Liu, Y., Li, H., Zhang, C., et al. (2019) · Cell Biology International · doi:10.1002/cbin.11139 · Cited by 36
He, Y., Miao, L., Yu, L., Chen, Q., Qiao, Y., Zhang, J. J., & Zhou, Y. M. (2019) · Dyes and Pigments · doi:10.1016/j.dyepig.2019.04.055 · Cited by 34
SH2 Domain-Containing Protein-Tyrosine Phosphatases
Neel, B. G., Chan, G., & Dhanji, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00098-x · Cited by 34
Growth hormone releasing hormone induces the expression of nitric oxide synthase
Barabutis, N., Siejka, A., & Schally, A. V. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01096.x · Cited by 34
Khan, R. I., & Pitchumani, K. (2016) · RSC Advances · doi:10.1039/c6ra01522k · Cited by 34
Malignancies and infection due to the human immunodeficiency virus. Are these emerging diseases?
Ortega, M. E. V. (2017) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2017.10.001 · Cited by 33
Bioresponsive probes for molecular imaging: concepts and in vivo applications
van Duijnhoven, S. M. J., Robillard, M. S., Langereis, S., & Grüll, H. (2015) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1636 · Cited by 34
CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients
de Oliveira, K. B., Guembarovski, R. L., Oda, J. M. M., Mantovani, M. S., Carreira, C. M., Reiche, E. M. V., Voltarelli, J. C., Herrera, A. C. D. S. D. A., & Watanabe, M. A. E. (2011) · Cytokine · doi:10.1016/j.cyto.2011.04.017 · Cited by 33
Suzuki, J., Nakajima, W., Suzuki, H., Asano, Y., & Tanaka, N. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.037 · Cited by 35
Huang, Y., Qiu, F., Chen, D., Shen, L., Xu, S., Guo, D., Su, Y., Yan, D., & Zhu, X. (2017) · Small · doi:10.1002/smll.201604062 · Cited by 33
Use of Zebrafish Embryos for Small Molecule Screening Related to Cancer
Terriente, J., & Pujades, C. (2012) · Developmental Dynamics · doi:10.1002/dvdy.23912 · Cited by 33
Pathophysiology of cancer therapy-provoked atrial fibrillation
Cheng, W., Kao, Y., Chen, S.-A., & Chen, Y. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.009 · Cited by 33
Reversible fluorescent probes for chemical and biological redox process
Li, B., He, Z., Zhou, H.-X., Zhang, H., & Cheng, T. (2017) · Chinese Chemical Letters · doi:10.1016/j.cclet.2017.08.055 · Cited by 33
Dai, F., Jin, F., Long, Y., Jin, X., & Zhou, B. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1446530 · Cited by 33
Occurrence of Anaerobic Bacteria in Diseases of the Dog and Cat
Berg, J. N., Fales, W. H., & Scanlan, C. M. (1979) · American Journal of Veterinary Research · doi:10.2460/ajvr.1979.40.06.876 · Cited by 33
Mistri, T., Alam, R., Dolai, M., Mandal, S. K., Khuda‐Bukhsh, A. R., & Ali, M. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob27405e · Cited by 33
Han, Z., Liang, X. H., Ren, X., Shang, L., & Yin, Z. (2016) · Chemistry - An Asian Journal · doi:10.1002/asia.201501304 · Cited by 32
Xu, J., Zhai, J., Xu, Y., Zhu, J., Qin, Y., & Jiang, D. (2016) · The Analyst · doi:10.1039/c6an00262e · Cited by 32
The Human Body as a Super Network: Digital Methods to Analyze the Propagation of Aging
Whitwell, H. J., Bacalini, M. G., Blyuss, O. B., Chen, S., Garagnani, P., Gordleeva, S. Y., Jalan, S., Ivanchenko, M., Игоревич, К. О., Кустикова, В. Д., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00136 · Cited by 34
Osteopontin - The stirring multifunctional regulatory factor in multisystem aging
Du, Y., Mao, L., Wang, Z., Yan, K., Zhang, L., & Zou, J. T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1014853 · Cited by 34
Ma, D., Yuan, Y. L., Yu, X., Zhang, M., & Yang, Y. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2578 · Cited by 32
Lam, C. R. I., Tan, M., Tan, S. H., Tang, M. B. Y., Cheung, P. C. F., & Tan, N. S. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2010.182 · Cited by 32
Dotto, G. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3750 · Cited by 33
Yang, F. W., Yang, Y., Mao, C., Cao, B., Cai, Z.-L., Shi, J., Huang, J., Zhang, P., & Liu, C.-F. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.027 · Cited by 33
Embryonic stem cells: a novel paradigm to study proteostasis?
Lee, H. J., Gutiérrez-García, R., & Vı́lchez, D. (2016) · FEBS Journal · doi:10.1111/febs.13810 · Cited by 32
Antonio, M., Carmona‐Bayonas, A., Saldaña, J., Navarro, V., Tebé, C., Salazar, R., & Borràs, J. M. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.09.003 · Cited by 32
Kang, Y. Q., Li, C., Shi, H., Zhang, A., Huang, C., Zhou, C., & Jia, N. (2023) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202300216 · Cited by 31
Aging as a loss of morphostatic information: A developmental bioelectricity perspective
Pio‐Lopez, L., & Levin, M. G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102310 · Cited by 36
Excellent benzocoumarin-based ratiometric two-photon fluorescent probe for H 2 O 2 detection
Hao, X.-L., Guo, Z.-J., Zhang, C., & Ren, A. (2018) · Physical Chemistry Chemical Physics · doi:10.1039/c8cp06050a · Cited by 31
Nutritional Impact on Metabolic Homeostasis and Brain Health
Carneiro, L., & Pellerin, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.767405 · Cited by 33
Readily Accessible Fluorescent Probes for Sensitive Biological Imaging of Hydrogen Peroxide
Daniel, K. B., Agrawal, A., Manchester, M., & Cohen, S. M. (2013) · ChemBioChem · doi:10.1002/cbic.201200724 · Cited by 31
Morange, M. (2011) · Biological Theory · doi:10.1007/s13752-011-0010-6 · Cited by 32
Raj, S., Dsouza, L. A., Singh, S. P., & Kanwal, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598326 · Cited by 31
Urinary Phthalates and Leukocyte Telomere Length: An Analysis of NHANES 1999–2002
Scinicariello, F., Feroe, A. G., & Attanasio, R. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.027 · Cited by 30
Si, Y., Li, L., Qin, X., Bai, Y., Li, J., & Yin, Y. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.12.061 · Cited by 30
Korgaonkar, N., & Yadav, K. S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117060 · Cited by 30
Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer
Lee, D. D., Komosa, M., Sudhaman, S., Leao, R. R. N., Zhang, C. H., Apolónio, J. D., Hermanns, T., Wild, P. J., Klocker, H., Nassiri, F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146915 · Cited by 30
Orsburn, B. C., Escudero, B., Prakash, M., Gesheva, S. I., Liu, G., Huso, D. L., & Franco, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00091-10 · Cited by 34
Çağlar, B., İçer, F., Özdokur, K. V., Çağlar, S., Özdemir, A. O., Güner, E. K., Beşer, B. M., Altay, A., Çırak, Ç., Doğan, B., et al. (2021) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2021.124287 · Cited by 30
Ye, M., Zhang, W., Xu, H., Xie, P., Song, L., Sun, X., Li, Y., Wang, S., & Zhao, Q. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.08.172 · Cited by 29
Narlik‐Grassow, M., Blanco‐Aparicio, C., Cecilia, Y., Pérez, M., Muñoz-Galván, S., Cañamero, M., & Carnero, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060277 · Cited by 29
Jing, Y., Cao, Q., Liang, H., Yang, G., Hu, W.-L., Ji, L., & Mao, Z. (2017) · Chemical Communications · doi:10.1039/c7cc07797a · Cited by 29
Dual nanoenzymes loaded hollow mesoporous organotantalum nanospheres for chemo-radio sensitization
Peng, C., Liang, Y., Su, N., Chen, S., Yuan, Z., Chen, Y., Wu, D., Wu, B., Zhang, Y., Xu, Z., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.018 · Cited by 29
Silvestri, A., Vázquez‐Díaz, S., Misia, G., Poletti, F., López‐Domene, R., Pavlov, V., Zanardi, C., Cortajarena, A. L., & Prato, M. (2023) · Small · doi:10.1002/smll.202300163 · Cited by 29
David, M., & Kartheek, R. M. (2015) · Environmental Science and Pollution Research · doi:10.1007/s11356-015-5286-9 · Cited by 29
Siejka, A., Schally, A. V., & Barabutis, N. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0224-y · Cited by 29
Mei, Q., Li, Y., Li, B. N., & Zhang, Y. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.08.061 · Cited by 29
The molecular basis of longevity, and clinical implications
Marques, F. Z., Markus, M. A., & Morris, B. J. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.12.008 · Cited by 31
Coppola, D., Balducci, L., Chen, D., Loboda, A. P., Nebozhyn, M., Staller, A., Fulp, W. J., Dalton, W. S., Yeatman, T. J., & Brem, S. S. (2014) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2014.08.003 · Cited by 29
HIV Infection Is Associated with Shortened Telomere Length in Ugandans with Suspected Tuberculosis
Auld, E., Lin, J., Chang, E. G., Byanyima, P., Ayakaka, I., Musisi, E., Worodria, W. O., Davis, J. L., Segal, M. R., Blackburn, E. H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163153 · Cited by 30
Xiong, Y., WANG, Y., Zhang, J., Zhao, N., Zhang, A., Zhang, A., Zhao, D., Yu, Z., Yin, Y., Song, L., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01993-0 · Cited by 29
Sharma, S., Babu, M. A., Kumar, R., Singh, T. G., Dwivedi, A. R., Ahmad, G., Goel, K. K., & Kumar, B. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11112-x · Cited by 28
The Intricate Interplay between Mechanisms Underlying Aging and Cancer
Piano, A. (2014) · Aging and Disease · doi:10.14336/ad.2014.0209 · Cited by 28
Minor, R. K., López, M., Younts, C. M., Jones, B., Pearson, K. J., Anson, R. M., Diéguez, C., & de Cabo, R. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00693.x · Cited by 28
Shen, Y., Zhang, Y., Zhang, X., Zhou, X., Teng, X., Yan, M., & Bi, H. (2015) · Nanoscale · doi:10.1039/c4nr06269h · Cited by 28
Grandin, N., & Charbonneau, M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00817-08 · Cited by 29
Wulaningsih, W., Serrano, F. E. C., Utarini, A., Matsuguchi, T., & Watkins, J. A. (2016) · Oncotarget · doi:10.18632/oncotarget.11051 · Cited by 28
Energy Metabolism and Metabolic Sensors in Stem Cells: The Metabostem Crossroads of Aging and Cancer
Menéndez, J. A., & Joven, J. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_10 · Cited by 27
Hu, L., Han, S., Liu, Z., Parveen, S., Yuan, Y., & Xu, G. (2011) · Electrochemistry Communications · doi:10.1016/j.elecom.2011.10.016 · Cited by 27
Quinoline-based fluorescent probe for ratiometric detection of hydrogen peroxide in aqueous solution
Qian, Y.-Y., Xue, L., Hu, D.-X., Li, G., & Jiang, H. (2012) · Dyes and Pigments · doi:10.1016/j.dyepig.2012.05.013 · Cited by 28
Cao, Y. Q., Green, K., Quattlebaum, S. C., Milam, B., Lu, L., Gao, D., He, H., Li, N., Gao, L., Hall, F., et al. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0470-7 · Cited by 27
Zhou, L., Ding, H., Zhao, W., & Hu, S. (2018) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2018.08.042 · Cited by 27
Role of Endogenous Glucocorticoids in Cancer in the Elderly
Ayroldi, E., Cannarile, L., Adorisio, S., Delfino, D. V., & Riccardi, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123774 · Cited by 27
Metadata
- Authors
- Finkel, T., Serrano, M., & Blasco, M. A.
- Affiliations
- National Institutes of Health (US)
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Finkel, Toren
- Venue
- Nature
- Published
- 2007-08-16
- Volume
- 448
- Issue
- 7155
- Pages
- 767-774
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2134390575
- Cited by
- 988
- References
- 102
- Citations by year
- 2026: 13 · 2025: 31 · 2024: 33 · 2023: 41 · 2022: 53 · 2021: 62 · 2020: 59 · 2019: 52 · 2018: 69 · 2017: 56 · 2016: 73 · 2015: 67 · 2014: 52 · 2013: 52 · 2012: 43
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Ellison Medical Foundation
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cancer, aging, genomic instability, telomeres, autophagy, cellular senescence, carcinogenesis, mitochondrial metabolism, HeLa cells, history of cancer research, systems biology
- MeSH terms
- Animals, Autophagy, Humans, Neoplasms, Telomere, Cellular Senescence, Telomerase, Genomic Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review